FDA Approves Cancer Drug for a Biomarker Not a Tissue
May 31, 2017 8:26 pmColon, pancreatic, stomach, or ovarian cancer; it increasingly shouldn’t matter. In an era of precision medicine, the treatment approach should reflect the genetic makeup of the person’s tumor and the presence or absence of key biomarkers.
That ethos was set … Read more